QS116. Malignant Phylloides Tumor in the First Trimester of Pregnancy

ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS QS103. QUANTITATIVE GALACTOSE OXIDASE SCHIFF REACTION IN NIPPLE ASPIRATE FLUID MAY DISTINGUISH WOMEN WITH OR WITHOUT BREAST CANCER. A. B. Chagpar1, K. R. Clements1, C. Carte2, K. M. McMasters1, M. J. Evelegh2; 1 University of Louisville, Louisville, KY; 2PreMD, Inc., Hamilton, ON, Canada QS104. 3D-CT MAMMARY LYMPHOGRAPHY CAN HELP THE SELECTIVE AXILLARY NODE DISSECTION DIFFERED FROM THE ARM LYMPH FLOW. K. Yamashita, H. Akasu, T. Igarashi, T. Jikuzono, K. Hames, T. Hayakawa, K. Yanagihara, S. IIda, S. Haga, K. Shimizu; Nippon Medical School, Tokyo, Japan QS105. PREVALENCE BY RACE OF THE NOVEL ESTROGEN RECEPTOR GPR30 IN BREAST CANCER. E. A. Peralta1, S. Louis1, O. W. Kamel2; 1Southern Illinois Univ Sch of Medicine, Springfield, IL; 2Department of Pathology, Saint John’s Hospital, Springfield, IL QS106. SENTINEL LYMPH NODE BIOPSY USING SPECT-CT FUSION IMAGING IN PATIENTS WITH BREAST CANCER AND ITS CLINICAL USEFULNESS. H. Iwase, Y. Yamamoto, T. Kawasoe, M. Ibusuki; Kumamoto University, Kumamoto, Japan QS107. EVALUATION OF TOUCH PREPARATIONS FOR AUTOMATED INTRAOPERATIVE DETERMINATION OF SURGICAL MARGINS IN BREAST CANCER. M. Ruidiaz, S. Sandoval, M. J. Cortes, D. Martin, D. Messmer, J. Wang-Rodriguez, A. Kummel, S. L. Blair; University of California San Diego, LA Jolla, CA QS108. COMPLIANCE WITH HORMONAL CHEMOPROTECTION IN AN URBAN IMMIGRANT POPULATION OF BREAST CANCER PATIENTS. J. Au, G. Sugiyama, A. Cossu, J. J. Reilly, Jr.; SUNY-Downstate College of Medicine, New York, NY QS109. VALIDATION OF A CLINICAL PREDICTION RULE FOR PATIENTS’ LIKELIHOOD OF REQUIRING POSTMASTECTOMY RADIATION THERAPY. A. B. Chagpar1, P. Blumencranz2, P. W. Whitworth3, K. B. Deck4, A. Rosenberg5, R. Simmons6, D. S. Reintgen7, P. Beitsch8, T. B. Julian9, S. Saha10, A. Giuliano11, K. M. McMasters1, E. P. Mamounas12; 1University of Louisville, Louisville, KY; 2Morton Plant Mease Healthcare, Clearwater, FL; 3Nashville Breast Center, Nashville, TN; 4South Orange County Surgical Medical Group, Laguna Hills, CA; 5Jefferson University Hospital, Philadelphia, PA; 6Weill-Cornell Breast Center, New York, NY; 7Lakeland Regional Medical Center, Lakeland, FL; 8 Dallas Surgical Group, Dallas, TX; 9Allegheny General Hospital/ Allegheny Cancer Center, Pittsburgh, PA; 10McLaren Regional Medical Center, Flint, MI; 11John Wayne Cancer Institute at St. John’s Health Center, Santa Monica, CA; 12Aultman Hospital, Canton, OH QS110. TO ASSESS THE DIFFERENTIAL EFFECTS OF IODINE AND IODIDE ON MCF-7 BREAST CANCER CELLS. A. Goberdhan, F. R. Stoddard, II, B. Eskin, A. Brooks; Drexel University College of Medicine, Philadelphia, PA QS111. THE CHOICE OF PROCEDURE IN AN INDIGENT RACIAL MINORITY POPULATION WITH BREAST CANCER. J. A. Mouzakis1, M. Meyers1, E. Johnson1, H. Mesidor2, J. Coreil2, D. H. Shapiro3; 1University of South Florida, Tampa, FL; 2University of South Florida School of Public Health, Tampa, FL; 3University of South Florida Department of Surgery Division of Trauma Surgery, Tampa, FL

287

QS112. TRENDS IN SURGICAL MANAGEMENT OF EARLY BREAST CANCER. A. B. Chagpar, K. M. McMasters; University of Louisville, Louisville, KY QS113. IS SURGERY FOR INFLAMMATORY BREAST CANCERS UNDERUTILIZED, PARTICULARLY FOR AFRICAN AMERICAN PATIENTS? R. Yang, M. C. Cheung, D. Franceschi, J. Hurley, L. G. Koniaris; University of Miami, Miami, FL QS114. PATIENT PERCEPTION OF PHYSICIAN COMMITMENT AFFECTS QUALITY OF LIFE IN BREAST CANCER SURVIVORS. R. A. Greenup1, A. Lal1, A. Trentham-Dietz2; 1Medical College of Wisconsin, Milwaukee, WI; 2University of WisconsinMadison School of Medicine and Public Health, Madison, WI QS115. FACTORS CONTRIBUTING TO NONCONCORDANT PATHOLOGY RESULTS IN PATIENTS WITH A MAMMOGRAM OF BIRADS CLASSIFICATION IV. L. Weisfelner, A. Vogia, A. Brooks, M. Marcucci; Drexel University College of Medicine, Philadelphia, PA QS116. MALIGNANT PHYLLOIDES TUMOR IN THE FIRST TRIMESTER OF PREGNANCY. K. M. Blaker, S. Sahoo, M. R. Schweichler, A. Chagpar; University of Louisville, Louisville, KY QS117. TESTING AN ONCOLYTIC ADENOVIRUS FOR BREAST CANCER THERAPY USING A NOVEL EX VIVO TISSUE SLICE MODEL SYSTEM. K. M. Pennington, J. S. Jung, A. Nedeljkovic-Kurepa, B. D. Li, J. M. Mathis, Q. D. Chu; Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA QS118. EVALUATION OF ANDROGEN RECEPTOR AS A THERAPEUTIC TARGET IN BREAST CANCER. C. Martin, B. Singh, K. R. Cook, A. Lucci, Jr.; The University of Texas MD Anderson Cancer Center, Houston, TX QS119. A GERMLINE POLYMORPHISM IN SIPA1 DOES NOT PREDICT METASTATIC POTENTIAL IN BREAST CANCER. M. E. Danko, J. A. Olson, Jr., J. R. Marks; Duke University, Durham, NC QS120. TRENDS IN GENETIC TESTING IN THE UNITED STATES. A. B. Chagpar, K. M. McMasters; University of Louisville, Louisville, KY

ONCOLOGY 10: ENDOCRINE QS121. TRANSCRIPTOME ANALYSIS OF PARATHYROID ADENOMAS REVEALS MULTIPLE PHENOTYPIC GENE EXPRESSION SIGNATURES. B. R. Untch1, M. Abdelgadir Adam1, M. E. Barfield1, D. Dixit1, H. Dressman2, J. A. Olson, Jr.1; 1Department of Surgery, Duke University Medical Center, Durham, NC; 2 Institue for Genome Sciences and Policy, Duke University Medical Center, Durham, NC QS122. RECURRENT THYROID CARCINOMA: VICISSITUDES IN DIAGNOSIS. C. A. McGuire, T. W. Yen, E. A. Krzywda, S. D. Wilson, T. S. Wang; Medical College of Wisconsin, Milwaukee, WI QS123. YOUNG AGE AT DIAGNOSIS OF PAPILLARY THYROID CANCER IS ASSOCIATED WITH THE PRESENCE OF MULTIPLE SOMATIC MUTATIONS. W. Moses, J. Weng, Q. Duh, O. Clark, E. Kebebew; UCSF, San Francisco, CA